These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

240 related items for PubMed ID: 11167689

  • 1. The value of amino-terminal propeptide of type III procollagen in routine screening for methotrexate-induced liver fibrosis: a 10-year follow-up.
    Zachariae H, Heickendorff L, Søgaard H.
    Br J Dermatol; 2001 Jan; 144(1):100-3. PubMed ID: 11167689
    [Abstract] [Full Text] [Related]

  • 2. Monitoring patients on methotrexate: hepatic fibrosis not seen in patients with normal serum assays of aminoterminal peptide of type III procollagen.
    Maurice PD, Maddox AJ, Green CA, Tatnall F, Schofield JK, Stott DJ.
    Br J Dermatol; 2005 Mar; 152(3):451-8. PubMed ID: 15787813
    [Abstract] [Full Text] [Related]

  • 3. Serum type III procollagen aminopeptide for assessing liver damage in methotrexate-treated psoriatic patients.
    Boffa MJ, Smith A, Chalmers RJ, Mitchell DM, Rowan B, Warnes TW, Shomaf M, Haboubi NY.
    Br J Dermatol; 1996 Oct; 135(4):538-44. PubMed ID: 8915142
    [Abstract] [Full Text] [Related]

  • 4. Serum aminoterminal propeptide of type III procollagen. A non-invasive test for liver fibrogenesis in methotrexate-treated psoriatics.
    Zachariae H, Søgaard H, Heickendorff L.
    Acta Derm Venereol; 1989 Oct; 69(3):241-4. PubMed ID: 2566230
    [Abstract] [Full Text] [Related]

  • 5. Replacement of routine liver biopsy by procollagen III aminopeptide for monitoring patients with psoriasis receiving long-term methotrexate: a multicentre audit and health economic analysis.
    Chalmers RJ, Kirby B, Smith A, Burrows P, Little R, Horan M, Hextall JM, Smith CH, Klaber M, Rogers S.
    Br J Dermatol; 2005 Mar; 152(3):444-50. PubMed ID: 15787812
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate-induced liver cirrhosis. Clinical, histological and serological studies--a further 10-year follow-up.
    Zachariae H, Søgaard H, Heickendorff L.
    Dermatology; 1996 Mar; 192(4):343-6. PubMed ID: 8864370
    [Abstract] [Full Text] [Related]

  • 7. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ, Kuijpers AL, Buijs WC, Kniest PH, Corstens FH, Nagengast FM, de Boo T, Willems JL, Duller P, van de Kerkhof PC.
    Br J Dermatol; 1996 Mar; 134(3):481-7. PubMed ID: 8731673
    [Abstract] [Full Text] [Related]

  • 8. Validity of noninvasive markers of methotrexate-induced hepatotoxicity: a retrospective cohort study.
    Martyn-Simmons CL, Rosenberg WM, Cross R, Wong T, Smith CH, Barker JN.
    Br J Dermatol; 2014 Aug; 171(2):267-73. PubMed ID: 24942271
    [Abstract] [Full Text] [Related]

  • 9. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis and arthritis.
    Zachariae H, Aslam HM, Bjerring P, Søgaard H, Zachariae E, Heickendorff L.
    J Am Acad Dermatol; 1991 Jul; 25(1 Pt 1):50-3. PubMed ID: 1880254
    [Abstract] [Full Text] [Related]

  • 10. Abnormalities of serum type III procollagen aminoterminal peptide in methotrexate-treated psoriatic patients with normal liver histology do not correlate with hepatic ultrastructural changes.
    Oogarah PK, Rowland PL, Mitchell DM, Smith A, Chalmers RJ, Rowan B, Haboubi NY.
    Br J Dermatol; 1995 Oct; 133(4):512-8. PubMed ID: 7577576
    [Abstract] [Full Text] [Related]

  • 11. Liver fibrosis in patients with psoriasis and psoriatic arthritis on long-term, high cumulative dose methotrexate therapy.
    Lindsay K, Fraser AD, Layton A, Goodfield M, Gruss H, Gough A.
    Rheumatology (Oxford); 2009 May; 48(5):569-72. PubMed ID: 19273538
    [Abstract] [Full Text] [Related]

  • 12. Aminoterminal propeptide of type III procollagen in methotrexate-induced liver fibrosis and cirrhosis.
    Risteli J, Søgaard H, Oikarinen A, Risteli L, Karvonen J, Zachariae H.
    Br J Dermatol; 1988 Sep; 119(3):321-5. PubMed ID: 3179204
    [Abstract] [Full Text] [Related]

  • 13. The use of transient elastography and FibroTest for monitoring hepatotoxicity in patients receiving methotrexate for psoriasis.
    Lynch M, Higgins E, McCormick PA, Kirby B, Nolan N, Rogers S, Lally A, Vellinga A, Omar H, Collins P.
    JAMA Dermatol; 2014 Aug; 150(8):856-62. PubMed ID: 24964792
    [Abstract] [Full Text] [Related]

  • 14. Serum aminoterminal propeptide of type III procollagen in psoriasis and psoriatic arthritis: relation to liver fibrosis.
    Kanzler MH, Gorsulowsky D.
    J Am Acad Dermatol; 1992 Mar; 26(3 Pt 2):509. PubMed ID: 1564165
    [No Abstract] [Full Text] [Related]

  • 15. Liver biopsies and methotrexate: a time for reconsideration?
    Zachariae H.
    J Am Acad Dermatol; 2000 Mar; 42(3):531-4. PubMed ID: 10688735
    [No Abstract] [Full Text] [Related]

  • 16. Serum type III procollagen peptide, dynamic liver function tests and hepatic fibrosis in psoriatic patients receiving methotrexate.
    Mitchell D, Smith A, Rowan B, Warnes TW, Haboubi NY, Lucas SB, Chalmers RJ.
    Br J Dermatol; 1990 Jan; 122(1):1-7. PubMed ID: 2297495
    [Abstract] [Full Text] [Related]

  • 17. Plasma N-terminal propeptide of type III procollagen accurately predicts liver fibrosis severity in children with non-alcoholic fatty liver disease.
    Mosca A, Comparcola D, Romito I, Mantovani A, Nobili V, Byrne CD, Alisi A, Targher G.
    Liver Int; 2019 Dec; 39(12):2317-2329. PubMed ID: 31436362
    [Abstract] [Full Text] [Related]

  • 18. Serum levels of YKL-40 and PIIINP as prognostic markers in patients with alcoholic liver disease.
    Nøjgaard C, Johansen JS, Christensen E, Skovgaard LT, Price PA, Becker U, EMALD Group.
    J Hepatol; 2003 Aug; 39(2):179-86. PubMed ID: 12873813
    [Abstract] [Full Text] [Related]

  • 19. Have methotrexate-induced liver fibrosis and cirrhosis become rare? A matter for reappraisal of routine liver biopsies.
    Zachariae H.
    Dermatology; 2005 Aug; 211(4):307-8. PubMed ID: 16286736
    [No Abstract] [Full Text] [Related]

  • 20. Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis.
    Khan S, Subedi D, Chowdhury MM.
    Postgrad Med J; 2006 May; 82(967):353-4. PubMed ID: 16679477
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.